Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.7%

26 terminated/withdrawn out of 549 trials

Success Rate

90.4%

+3.9% vs industry average

Late-Stage Pipeline

10%

55 trials in Phase 3/4

Results Transparency

5%

12 of 244 completed trials have results

Key Signals

105 recruiting12 with results19 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
224(61.4%)
Phase 2
57(15.6%)
Phase 4
34(9.3%)
Phase 1
28(7.7%)
Phase 3
21(5.8%)
Early Phase 1
1(0.3%)
365Total
N/A(224)
Phase 2(57)
Phase 4(34)
Phase 1(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (549)

Showing 20 of 549 trials
NCT07624630Recruiting

Walking and Thinking - Brain Activity During Complex Walking in Stroke

Role: collaborator

NCT07611864Recruiting

Soft Tissue Radiation Injury; Patient Reported Evaluation in a Single Centre Cohort Study (STRIPE)

Role: lead

NCT07417787Recruiting

Point of Care Tests in the Management of Very Early Medical Abortion

Role: collaborator

NCT05776602Completed

Fast Brain MRI in Children With Suspected Brain Tumor

Role: lead

NCT07612943Not Yet Recruiting

ProspectiveMaleAYA - Frequency and Prediction of Therapy-induced Testicular Dysfunction in AYA Cancer Survivors

Role: collaborator

NCT07589868Not ApplicableActive Not Recruiting

A 10-Week Online Education Program for Women With Functional Hypothalamic Amenorrhea: Developing and Testing Feasibility and Acceptability

Role: collaborator

NCT06791317Completed

Intubation Checklist in the Intensive Care Unit

Role: lead

NCT07241715Phase 2Active Not Recruiting

Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)

Role: collaborator

NCT07351149Recruiting

Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery

Role: collaborator

NCT07580092Completed

Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease

Role: collaborator

NCT07577128Active Not Recruiting

Familial Risk of AAA in Sweden

Role: lead

NCT07560956Not Yet Recruiting

Quality of Life in Adults With Untreated Fabry Disease in Sweden (QoLUF)

Role: collaborator

NCT05190172Not ApplicableRecruiting

PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

Role: collaborator

NCT01558921Phase 3Active Not Recruiting

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

Role: collaborator

NCT07489274Phase 4Recruiting

Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial).

Role: collaborator

NCT05835284Completed

Clinical Data Collection On Advanced CT System

Role: collaborator

NCT03540420Phase 2Active Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Role: collaborator

NCT04269447Enrolling By Invitation

Prospective Aortic Biobank of POP-STAR

Role: lead

NCT07498959Not ApplicableRecruiting

Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

Role: collaborator

NCT06273644Not ApplicableRecruiting

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Role: collaborator